We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amgen Sues Roche Over Anemia Treatment

Law360 (November 9, 2005, 12:00 AM EST) -- Biotechnology company Amgen Inc., the largest in the world, has filed a lawsuit against three subsidiaries of rival Roche Holding AG, claiming the U.S. patents for its multi-billion dollar anemia treatments are infringed by Roche’s U.S. activities.

Amgen is seeking a declaratory judgment of infringement by Switzerland-based Roche, as well as its subsidiaries F. Hoffmann-LaRoche Ltd., Roche Diagnostics GmbH and Hoffmann-LaRoche Inc. It was filed in the U.S. District Court for the District of Massachusetts.

The treatment in the case, Epogen, is a recombinant version of...
To view the full article, register now.